Cleared Traditional

URINE COCAINE METABOLITE SCREEN FLEX(TM) REAGENT CATRIDGE

K950134 · E.I. Dupont DE Nemours & Co., Inc. · Toxicology
Mar 1995
Decision
67d
Days
Class 2
Risk

About This 510(k) Submission

K950134 is an FDA 510(k) clearance for the URINE COCAINE METABOLITE SCREEN FLEX(TM) REAGENT CATRIDGE, a Hemagglutination, Cocaine Metabolites (benzoylecgnonine) (Class II — Special Controls, product code DLN), submitted by E.I. Dupont DE Nemours & Co., Inc. (Wilmington, US). The FDA issued a Cleared decision on March 21, 1995, 67 days after receiving the submission on January 13, 1995. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3250.

Submission Details

510(k) Number K950134 FDA.gov
FDA Decision Cleared SESE
Date Received January 13, 1995
Decision Date March 21, 1995
Days to Decision 67 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF

Device Classification

Product Code DLN — Hemagglutination, Cocaine Metabolites (benzoylecgnonine)
Device Class Class II — Special Controls
CFR Regulation 21 CFR 862.3250